CJ CheilJedang FY 2025 Annual Report
Beta

Filed: March 16, 2026· period ending December 31, 2025DART

CJ CheilJedang annual report for FY 2025, filed with DART (Korea Financial Supervisory Service) on March 16, 2026. This page provides AI-powered English analysis including business overview, management discussion & analysis (MD&A), risk factors, and KIFRS consolidated financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE).

CJ CheilJedang FY 2025 Annual Report Analysis

Business Overview

• CJ Jedang (CJ제일제당) signed SPA to divest Feed Care (F) segment — 14 subsidiaries including CJ Feed & Care — reclassified as discontinued operations in FY2025
• Total consolidated revenue KRW 27.34T (FY2025), up from KRW 27.24T; food 42%, logistics 43%, BIO 15%

Management Discussion & Analysis

• Revenue KRW 27.34T (+0.4% YoY); OP KRW 1.23T (-15.0% YoY); net loss KRW 417.0B (vs. net income KRW 345.9B prior year)
• BIO segment OP fell 35.1% to KRW 202.1B — tryptophan, specialty amino acids hit by competition-driven ASP decline and unfavorable market conditions

Risk Factors

• Financial liabilities due within 1 year total KRW 8.72T, including short-term borrowings KRW 2.79T and current portion of long-term debt/bonds KRW 2.19T
• NEW in FY2025: put option provided Jun 2025 on senior ABL loan backed by CJ Jedang Center fund, notional KRW 90.6B, expiring Jun 2030

CJ CheilJedang FY 2025 Key Financial Metrics
DART

Total Assets

KRW 29.74T

▼ -1.3% YoY

Operating Cash Flow

KRW 2.48T

▲ +10.0% YoY

CapEx

KRW 1.63T

▲ +62.9% YoY

Source: KIFRS consolidated financial data from CJ CheilJedang annual report on DART. All figures in KRW.

Source: DART (Korea Financial Supervisory Service) · AI summaries generated from the original Korean filing (English output) · Beta: coverage is expanding